Here are the DEF 14A proxy statements from IN8bio, Inc. (INAB) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow INAB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full INAB filings page.
IN8bio, Inc. is calling a virtual 2026 annual stockholder meeting on May 7, 2026, to elect two Class II directors, ratify CohnReznick LLP as auditor, and approve an Amended and Restated 2026 Equity Incentive Plan.
As of the March 18, 2026 record date, 9,847,089 shares of common stock were outstanding and entitled to vote. The new 2026 equity plan would authorize 4,054,937 shares for awards, including 2,920,000 new shares plus remaining and returning shares from prior plans, and features an automatic annual share increase formula tied to common shares and pre-funded warrants outstanding.